Form 8-K - Current report:
SEC Accession No. 0001628280-23-027011
Filing Date
2023-08-03
Accepted
2023-08-03 07:40:56
Documents
16
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lnth-20230802.htm   iXBRL 8-K 33980
2 EX-99.1 exhibit991q22023earningspr.htm EX-99.1 247718
3 EX-99.2 exhibit992q22023relistorro.htm EX-99.2 15130
7 newlantheuslogo.jpg GRAPHIC 3408
8 newlantheuslogoa.jpg GRAPHIC 3408
  Complete submission text file 0001628280-23-027011.txt   455570

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20230802.xsd EX-101.SCH 1904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20230802_lab.xml EX-101.LAB 23834
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20230802_pre.xml EX-101.PRE 12510
10 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20230802_htm.xml XML 2832
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 231138108
SIC: 2835 In Vitro & In Vivo Diagnostic Substances